Published 4 days ago • loading... • Updated 4 days ago
What Cipher Pharmaceuticals (CPH) Said on Its Q3 Earnings Call
Summary by MarketBeat
3 Articles
3 Articles
What Cipher Pharmaceuticals (CPH) Said on Its Q3 Earnings Call
Cipher Pharmaceuticals (TSE:CPH) reported nearly flat third-quarter revenue as growth in its Canadian acne treatment Epuris and higher licensing revenue largely offset lower U.S. sales of Natroba. Net income almost doubled, helped by the recognition of proceeds from an arbitration award. Revenue fo
What Hydro One (H) Said on Its Q3 Earnings Call
Hydro One (TSE:H) reported a slight decline in third-quarter earnings as higher operating, depreciation and interest costs outweighed revenue gains, while management outlined a proposed CAD 27 billion investment plan for its transmission and distribution businesses from 2028 through 2032. Basic earnings per share slipped to CAD 0.69 from CAD 0.70 a year earlier, and […]
Coverage Details
Total News Sources3
Leaning Left0Leaning Right1Center1Last Updated50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium







